Clinical assessment of CL22209, a standardized proprietary extract of Asparagus racemosus , for mitigating vasomotor and menstrual symptoms in perimenopausal women:  A randomized, double-blind, placebo-controlled study | Functional Foods in Health and Disease - Online ISSN: 2160-3855; Print ISSN: 2378-7007 Skip to main content Skip to main navigation menu Skip to site footer Open Menu Functional Foods in Health and Disease - Online ISSN: 2160-3855; Print ISSN: 2378-7007 Home Food Science Publisher Functional Food Center Current Archives About About the Journal Aims and Scope Contact Editing Services Editorial Team Express Peer Review Graphical Abstract Journal Insights Privacy Statement Submissions Announcements Search Search Register Login Home / Archives / Vol. 15 No. 7 (2025): July 2025 / Research Articles Clinical assessment of CL22209, a standardized proprietary extract of Asparagus racemosus, for mitigating vasomotor and menstrual symptoms in perimenopausal women:  A randomized, double-blind, placebo-controlled study Authors Poonam Yadav Suman Yadav Sai Sarada Vedururu Gayatri Kiumari DOI: https://doi.org/10.31989/ffhd.v15i7.1684 Abstract Background: Vasomotor symptoms (VMS) and menstrual discomfort are prevalent and distressing manifestations during the menopausal transition in women, significantly impairing the quality of life (QoL). Asparagus racemosus Willd. (family: Asparagaceae) (Shatavari), a revered Rasayana herb in Ayurvedic medicine, has long been used to support female reproductive health.  Objective: We investigated the therapeutic potential of CL22209, a standardized A racemosus root extract, in early perimenopausal women. Precisely, it assessed the extract’s ability to alleviate vasomotor symptoms, menstrual discomfort, and hormonal dysregulation through a comprehensive evaluation of symptom scores, reproductive hormone levels, ovarian follicle counts, and patient-reported outcomes, and ensuring its safety and tolerability over a 120-day supplementation. Methods: In this randomized, double-blind, placebo-controlled investigation, 75 early perimenopausal women (aged 40–50 years) with mild-to-moderate VMS were assigned to receive either CL22209 (50- or 100 mg/day) or placebo over a period of 120 consecutive days. The primary endpoint was the change in total Menopausal Rating Scale (MRS) scores. Secondary outcomes included Hot Flash Weekly Weighted Score (HFWWS), Menstrual Symptom Questionnaire (MSQ) score, follicle count via ultrasonography, and serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), anti-Müllerian hormone (AMH), and 17β-estradiol (E2) in the participants. Skin and hair quality, as well as patient-reported outcomes, were also assessed. Safety and tolerability were evaluated through monitoring of hematology, clinical biochemistry, urinalysis, and adverse events. Results: Supplementation with CL22209 at both 50 mg and 100 mg/day significantly reduced MRS scores and HFWWS as compared to baseline and placebo (p < 0.001). Menstrual symptoms, particularly spasmodic and congestive dysmenorrhea, showed marked improvement. Notably, a dose-dependent modulation of FSH, LH, AMH, and E2 levels was observed. No serious adverse events were reported. Conclusion: CL22209 demonstrates the efficacy and safety profile as a natural, non-hormonal intervention for alleviating perimenopausal symptoms, providing clinical benefits in symptom reduction, hormonal regulation, and dermatological well-being. The study provides the first clinical evidence of CL22209’s dual central and peripheral endocrine modulation, positioning it as a novel functional food for integrative women's health support during the menopausal transition. Keywords: Asparagus racemosus (Shatavari), Functional Food, Hormonal balance, Menopausal Rating Scale (MRS), Perimenopause. Phytoestrogens, Safety, Vasomotor symptoms. Downloads [Abstract] [Full Article] Published 2025-07-23 Issue Vol. 15 No. 7 (2025): July 2025 Section Research Articles License Copyright (c) 2025 Functional Foods in Health and Disease This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Authors retain the copyright of their articles and grant the Functional Food Center (FFC) and its journals the right of first publication under the terms of the Creative Commons Attribution 4.0 International License. This license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, provided the original author(s) and source are properly credited. Authors may post and share their published work freely, provided that the original publication in this journal is acknowledged. By submitting to this journal, authors confirm that their manuscripts are original, not under consideration elsewhere, and that they hold the necessary rights to grant this license. The Functional Food Center encourages open scientific exchange and allows derivative and extended works, provided attribution to the original publication is maintained. About the Journal      Editing Services      Graphical Abstract      Journal Insights        Submissions        Editorial Team       Privacy Statement        Contact        Current        Archives   Open Journal Systems Hosting and Support by: OpenJournalSystems.com